These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 9636524

  • 21. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G, Tarantino A, Aroldi A, Banfi G, Cesana B, Ponticelli C.
    Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract] [Full Text] [Related]

  • 22. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy.
    Zucker K, Rosen A, Tsaroucha A, de Faria L, Roth D, Ciancio G, Esquenazi V, Burke G, Tzakis A, Miller J.
    Transplant Proc; 1997 Oct; 29(1-2):334-6. PubMed ID: 9123027
    [No Abstract] [Full Text] [Related]

  • 23. Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.
    Akman B, Uyar M, Afsar B, Sezer S, Ozdemir FN, Haberal M.
    Transplant Proc; 2007 Oct; 39(1):135-7. PubMed ID: 17275490
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Tacrolimus for rescue therapy in refractory renal allograft rejection.
    Jang HJ, Kim SC, Han DJ.
    Transplant Proc; 2000 Nov; 32(7):1765-6. PubMed ID: 11119925
    [No Abstract] [Full Text] [Related]

  • 27. Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience.
    Lye WC.
    Transplant Proc; 2000 Nov; 32(7):1700-1. PubMed ID: 11119898
    [No Abstract] [Full Text] [Related]

  • 28. Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.
    Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Hené RJ, Blom HJ, Demacker PN, Hilbrands LB.
    Transplant Proc; 2002 Aug; 34(5):1793-4. PubMed ID: 12176579
    [No Abstract] [Full Text] [Related]

  • 29. [Immunosuppressive therapy without calcineurin inhibitors for renal transplants? Perhaps we should be cautions...].
    Fasoli G.
    G Ital Nefrol; 2007 Aug; 24(2):110. PubMed ID: 17458825
    [No Abstract] [Full Text] [Related]

  • 30. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y, Takahara S, Kyo M, Ichimaru N, Toki K, Wang JD, Okuyama A.
    Transplant Proc; 1999 Aug; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract] [Full Text] [Related]

  • 31. Does cyclosporine influence the outcome in patients with acute tubular necrosis after renal transplantation.
    Ritz M, Botha J, Pontin AR, Pascoe MD, Kahn D.
    Transplant Proc; 1999 Aug; 31(1-2):303. PubMed ID: 10083117
    [No Abstract] [Full Text] [Related]

  • 32. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
    Sperschneider H, European Renal Transplantation Study Group.
    Transplant Proc; 2001 Aug; 33(1-2):1279-81. PubMed ID: 11267291
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
    Bakar F, Keven K, Dogru B, Aktan F, Erturk S, Tuzuner A, Erbay B, Nebioglu S.
    Transplant Proc; 2009 Jun; 41(5):1630-3. PubMed ID: 19545695
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Transplantation without maintenance corticosteroids in 1-haplotype and 2-haplotype HLA matched living-related renal transplant recipients treated with mycophenolate mofetil and cyclosporine.
    Kupin W, Venkat KK, Goggins M, Douzdjian V, Escobar F, Mozes M, Abouljoud M.
    Transplant Proc; 1999 Jun; 31(1-2):744-5. PubMed ID: 10083317
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.